
Dupixent Cancer Lawsuit Update: 2026 Patient Reference Guide
Introduction Dupixent Cancer Lawsuit Update: Dupixent (dupilumab) is a widely used injectable biologic prescribed for inflammatory diseases such as atopic dermatitis (eczema), asthma, chronic rhinosinusitis